Valuation: EDAP TMS S.A.

Market Cap 189M 164M 154M 140M 263M 18.1B 265M 1.84B 711M 9.18B 709M 694M 29.19B P/E 2026 *
-3.45x
P/E 2027 * -5.35x
Enterprise Value 189M 164M 154M 140M 263M 18.1B 265M 1.84B 711M 9.18B 709M 694M 29.19B EV / Sales 2026 *
3.63x
EV / Sales 2027 * 2.71x
Free-Float
32.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.24%
1 week-0.96%
Current month-3.75%
1 month-13.66%
3 months-12.92%
6 months+4.85%
Current year+24.92%
1 week 4.01
Extreme 4.01
4.3
1 month 4.01
Extreme 4.01
4.82
Current year 3.1
Extreme 3.1
6.4
1 year 1.75
Extreme 1.75
6.4
3 years 1.21
Extreme 1.21
8.5
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 2023-04-30
Director of Finance/CFO 55 2023-12-31
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 64 2023-07-31
Chairman 64 2024-08-31
Director/Board Member 62 2024-07-07
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/26 Buy

Chief Financial Officer

5,000 0.0133%
8/14/26 Buy

Director

10,000 0.0267%
8/14/26 Buy

Chairman

50,000 0.1334%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%-0.96%+67.76%-39.20% 189M
+0.62%-0.03%+27.98%+19.00% 227B
+1.55%-2.12%+6.95%-19.82% 143B
+2.38%+3.07%-15.95%+24.43% 134B
+4.82%-5.75%-56.14%-14.87% 65.29B
+1.99%+0.96%-18.12%-13.93% 50.09B
+1.36%-4.87%+10.25%+15.54% 49.29B
-0.09%-2.69%+19.12%+27.79% 41.39B
+0.41%+0.15%+38.80%+50.73% 40.28B
+2.16%-2.35%-17.45%+51.04% 31.9B
Average +1.32%-1.66%+6.32%+10.07% 78.17B
Weighted average by Cap. +1.45%-0.91%+3.78%+11.07%

Financials

2026 *2027 *
Net sales 52M 45.05M 42.52M 38.57M 72.36M 4.98B 72.88M 508M 196M 2.53B 195M 191M 8.04B 69.73M 60.42M 57.02M 51.73M 97.04M 6.68B 97.74M 681M 262M 3.39B 262M 256M 10.78B
Net income -47.66M -41.3M -38.97M -35.36M -66.33M -4.57B -66.81M -465M -179M -2.32B -179M -175M -7.37B -31.59M -27.37M -25.83M -23.43M -43.96M -3.03B -44.28M -308M -119M -1.54B -119M -116M -4.88B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
26-09-14 US$4.110 +0.24% 59,933
26-09-11 US$4.100 -1.44% 66,302
26-09-10 US$4.160 -0.95% 112,865
26-09-09 US$4.200 -0.24% 87,400
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.110USD
Average target price
8.600USD
Spread / Average Target
+109.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!